article thumbnail

CLU's Gerhard Apfelthaler: What I Learned In 2014

socalTECH

We''re continuing to feature reflections on the last year from movers and shakers in the local high tech community, and today have thoughts from Gerhard Apfelthaler , who is Dean of California Lutheran University''s School of Management , which has been very active in Ventura County helping to promote startup and entrepreneurial activity.

article thumbnail

Ceres Prices IPO

socalTECH

Thousand Oaks-based Ceres , the developer of specialized seeds for the biofuels market, has priced its IPO, saying that it will offer up 5,000,000 shares of its common stock at $13.00 The firm will start trading today on the NASDAQ Global Market as CERE. The IPO was underwritten by Goldman, Sachs & CO.,

Pricing 150
article thumbnail

Bio Roundup: CAR-T & Migraine Races, Intra-Cellular, Rockefeller & More

Xconomy

—Amgen (NASDAQ: AMGN ), of Thousand Oaks, CA, and partner Novartis released positive results from the first Phase 3 trial of erenumab , one of a group of drugs being developed to prevent migraines , not just lessen their impact when they happen. . Phase 3 trials should start next year. TheStreet.com has more here.

Avalon 40